MORRISVILLE, N.C. & KUOPIO, Finland--(BUSINESS WIRE)--Clinipace Worldwide, a global digital contract research organization (dCRO), today announced a strategic partnership with Nordic-based CRO, Medfiles.
Founded in Finland in 1987, Medfiles brings an extensive 25-year history serving the Nordic and Baltic regions of the EU. The company specializes in pharmaceutical development and analytical services, clinical trial support, health economics, and regulatory affairs.
The combined geofootprint of this partnership opens both companies to new global opportunities. While Medfiles clients gain access to Clinipace’s proprietary technology, TEMPO™ eClinical platform, the partnership provides Clinipace clients access to Medfiles’ local knowledge, services, and staff across the Nordics and Baltic countries.
“We are impressed with Medfiles’ track record of fruitful cooperation and tradition of long-term relationships and in-depth partnering with client,” noted Ran Frenkel, RPh, Managing Director, EMEA, Clinipace Worldwide. “The company’s philosophy of building quality standards and procedures fits seamlessly with the way we conduct our business.”
Founded in Finland in 1987, Medfiles is a private contract research organization (CRO) serving the Scandinavian (Finland, Sweden, Denmark, and Norway) and Baltic countries (Estonia, Lativia, and Lithuania.) Our services include pharmaceutical development and analytical service, clinical trial support, health economics, and regulatory affairs (i.e., marketing authorization and pharmacovigilance), culminating in our “one-stop-shop” service package. For more detailed information, please refer to www.medfiles.fi, or contact Declan Flaherty, Business Development Director, Ph: +358 400 931 422.
About Clinipace Worldwide
As a global full-service digital contract research organization (dCRO), we have pioneered an innovative technology-amplified CRO service model to serve the unique needs of venture-backed, mid-tier, and strategic pharmaceutical, biotechnology, and medical device firms. Powered by TEMPO™, our proprietary eClinical platform, our team of experts brings extensive therapeutic knowledge and insight into assisting life science firms in developing and executing regulatory strategies, clinical development, and post-approval research to ensure a successful drug and medical device development program. We have managed over 1,200 global clinical research, strategic product development, regulatory, and GxP/CMC/QA projects in therapeutic areas such as cardiovascular & metabolic diseases, central nervous system, dermatology, gastroenterology, immunology, infectious diseases, nephrology, oncology, respiratory, rheumatology, and vaccines (and other cell and tissue based therapies). Clinipace Worldwide is headquartered in Research Triangle Park, North Carolina with offices in Irvine (CA), Boulder (CO), Overland Park (KS), Zurich (CH), Munich (DE), High Wycombe (UK), Tel-Aviv (IL), Sao Paulo (BR), Buenos Aires (AR), Trivandrum Kerala (IN) and New Delhi (IN). For more information, visit our website at www.clinipace.com.